Navigation Links
Could Long Tern Vioxx Users Suffer From Heart Attacks?

Dr. Barry Rayburn, a cardiologist from the University of Alabama, Birmingham, told a jury at the latest Vioxx product liability trial that the drug showed no significant difference in the rate of heart attacks //among its users and those taking similar drugs or placebos. The drug Vioxx is produced and marketed by Merck & Co.'s. The doctor testified on Tuesday and told a jury that the studies, covering a total of about 28,000 patients, contained no evidence that Vioxx exposed users to a higher rate of heart attacks and other cardiovascular events than comparable drugs or sugar pills.

The data collected from 28000 patients doesn't show any evidence that there is an increased risk of these kinds of events in patients taking Vioxx. Merck is being sued by Thomas Cona, 59, and John McDarby, 77 who are both long-term Vioxx users. They blame the drug and the company for their heart attacks. The doctor also pointed out to the study published in 2000 of some 8,000 rheumatoid arthritis patients. It was showed that these patients showed a higher rate of heart attacks among Vioxx users because the drug was compared to a protective effect of naproxen.

It is a common pain drug to which Vioxx was being compared but it did not prove that Vioxx increased cardiovascular risk. When the doctor was questioned about another study which involved 5,500 osteoarthritis patients showing five heart attacks among Vioxx users compared with one for those taking naproxen, he dismissed that the data was not statistically significant. He pointed to the same study and revealed that the study found six strokes among naproxen users and none for Vioxx patients. Merck pulled its $2.5 billion-a-year pain drug off the market in September 2004 after a study showed it doubled the risk of heart attack and stroke in patients.

The current trial is the first to involve long-term Vioxx users. About 10,000 lawsuits that have been filed against Merck over Vioxx drug complications. Th
'"/>




Page: 1 2

Related medicine news :

1. Lean Protein Could Be Key to Obesity Drugs
2. Nasal Spray Could Take Drugs Direct to Brain.
3. Nasal Spray Could Take Drugs Directly to Brain
4. Oxygen Usage During Exercise Could Indicate Heart Problems
5. Ultrasound Screening Could Improve The Outcome Of Critically ill Patients
6. Anger Could Be Linked To Weight Gain
7. A Seizure Late In Life Could be A Stroke Warning
8. New Findings Could Reduce The Extent Of Spinal Cord Injuries
9. Could There Be A Link Between Famine and Breast Cancer ?
10. Bone Marrow Cells Could Yield A New Lease of Life
11. New Hair in 15 Days Could Now Be A Possibility Say Researchers
Post Your Comments:
(Date:12/2/2008)... form an integral part of most of,original equipm...ore become,essential for service providers in the...in competitive and constantly improve their servic...: http://www.newscom.com/cgi-bin/prnh/20081117/F...livan ( http://www.medicalimaging.frost.com ),Eur...
(Date:12/2/2008)...ctation Service, one of the premier leaders in med...egal dictation transcription, has joined up with ...organization geared to the betterment of women and...ughout Lower Westchester County, New York. , ..., 2008 -- World Wide Dictation Services of New Yor...
(Date:12/2/2008)...s ASHP midyear meeting, FFF Enterprises, the natio...al-care biopharmaceuticals and vaccines, will unve...rity and demonstrate how the company has taken pha...439) , (Vocus) December 2... Enterprises, the nation,s largest and most truste...
(Date:12/2/2008)...lies, the problem with the holidays is family. El...how caregivers of aging parents can bring the joy .... , San Mateo, CA (PRWEB)...of the holiday season is family, especially aging ...her Koch , founder of Encore Management , has a s...
Breaking Medicine News(10 mins):Health News:Encouraging Prospects for Medical Imaging Equipment Services in Europe 2Health News:Encouraging Prospects for Medical Imaging Equipment Services in Europe 3Health News:World Wide Dictation Service Teams up with TMATT for Local Thanksgiving Community Dinner 2Health News:FFF Enterprises Unveils ‘The 8 Critical Steps to Guaranteed Channel Integrity' at the American Society of Health-System Pharmacists (ASHP) Midyear Meeting in Orlando 2Health News:FFF Enterprises Unveils ‘The 8 Critical Steps to Guaranteed Channel Integrity' at the American Society of Health-System Pharmacists (ASHP) Midyear Meeting in Orlando 3Health News:Holidays with Aging Parents: Elder Care Expert Has the Prescription for Caregiver Stress 2Health News:Holidays with Aging Parents: Elder Care Expert Has the Prescription for Caregiver Stress 3
...ctions are both of great public health importance ...gues have found that acute malaria episodes are as...oad in the blood,// and they speculate that malari...ase progression and facilitate transmission. Evid...
...ed today at the 47th Annual Meeting of the America...n Denver, Colorado say that there is no direct lin...he aggressiveness of prostate cancer, but the long...ers at Fox Chase Cancer Center found no correlatio...
...has been conducted to understand how the sexes dif...n differ in their inflammatory reactions to work-r..., different strategies would have to be devised to... It has also been shown that work-related burnout ...
...tree like, diffuse articular lipomatosis) is a rar...ogy. //It is a very rare primary benign tumour of ...iagnosis for a slowly progressive chronically swol...rescens have previously been reported, usually inv...
Other Medicine News:Health News:Malaria infection can accelerate HIV infection and disease progression 2Health News:Sexes differ in response to burnout on the job and depression 2Health News:Lipoma Arborescens: A Rare Tumor Of The Knee 2
(Date:12/1/2008)...EGO, Dec. 1 Vical Incorp...pt of a $1.0 million milestone payment from Merck ...n of a Phase I clinical trial of an investigationa... vaccine is based on Vical,s DNA gene delivery tec...criptase (hTERT). hTERT is the subject of separate...
(Date:11/27/2008)...udy finds the majority of acute lymphoblastic leuk...nt at the time of diagnosis , , MEMPHIS, Te... at St. Jude Children,s Research Hospital have ide...cells of children with acute lymphoblastic leukemi...athway to designing treatments for ALL relapse in ...
(Date:11/25/2008)...ILLE, Ky., Nov. 25 Klei...eons performed the fifth U.S. hand transplant on M... Louisville,s Jewish Hospital Hand Care Center on ...an around noon and was completed shortly after 9 p...ttp://www.newscom.com/cgi-bin/prnh/20081125/DC4855...
(Date:11/25/2008)...tients Enrolled in Clinical Trial to Assess Surviv...are Therapies for Unresectable Hepatocellular Carc...ire/ -- Light Sciences Oncology, Inc. (LSO) today ... Phase 3 clinical trial of Light Infusion Therapy(...atocellular carcinoma (HCC), also known as hepatom...
Breaking Medicine Technology:Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 3Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 2Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 2Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 4Dynatronics Announces 24250 000 Increase in Stock Buyback Program 7510 1Dynatronics Announces 24250 000 Increase in Stock Buyback Program 7510 2In the Forefront of Research into Protein Folding and Macromolecular Complex Assembly 7505 1In the Forefront of Research into Protein Folding and Macromolecular Complex Assembly 7505 2In the Forefront of Research into Protein Folding and Macromolecular Complex Assembly 7505 3In the Forefront of Research into Protein Folding and Macromolecular Complex Assembly 7505 4In the Forefront of Research into Protein Folding and Macromolecular Complex Assembly 7505 5In the Forefront of Research into Protein Folding and Macromolecular Complex Assembly 7505 6Exercising our immune system 7500 1Exercising our immune system 7500 23 Common Drugs Trigger Most ER Visits by Seniors 7496 13 Common Drugs Trigger Most ER Visits by Seniors 7496 2
...re-FirstCall/ Haemacure,Corporation , a Montreal-b...unced the preliminary findings of the content anal...findings confirm the presence of a number of,prote...orldwide,markets, including albumin, plasminogen, ...a strategic significance for Haemacure as,revenues...
...-FirstCall/ --,Bristol-Myers Squibb Company today ...y of ORENCIA(R) (abatacept) from the open-label,ph...n with juvenile,idiopathic arthritis (JIA) who hav...e-modifying anti- rheumatic drugs (DMARDs), such,a...) antagonists.,The results demonstrated that, afte...
Other Medicine Technology:Haemacure Announces Preliminary Findings of its Plasma Discard,Analysis 2Haemacure Announces Preliminary Findings of its Plasma Discard,Analysis 3Haemacure Announces Preliminary Findings of its Plasma Discard,Analysis 4Investigational Study Demonstrated a Re-Establishment of Clinical,Improvement with Orencia (Abatacept) in Children with Juvenile,Idiopathic Arthritis upon Re-Introduction of Therapy 2Investigational Study Demonstrated a Re-Establishment of Clinical,Improvement with Orencia (Abatacept) in Children with Juvenile,Idiopathic Arthritis upon Re-Introduction of Therapy 3Investigational Study Demonstrated a Re-Establishment of Clinical,Improvement with Orencia (Abatacept) in Children with Juvenile,Idiopathic Arthritis upon Re-Introduction of Therapy 4Investigational Study Demonstrated a Re-Establishment of Clinical,Improvement with Orencia (Abatacept) in Children with Juvenile,Idiopathic Arthritis upon Re-Introduction of Therapy 5Investigational Study Demonstrated a Re-Establishment of Clinical,Improvement with Orencia (Abatacept) in Children with Juvenile,Idiopathic Arthritis upon Re-Introduction of Therapy 6
Solid 8 mm blades. Dull finish. Most popular size or model.
Open 10 mm blades. Dull finish.
Open 14 mm blades of heavy 1 mm wire. Dull finish. Most popular size or model.
Fenestrated 14 mm blades. Self-locking mechanism. Dull finish.
Medicine Products: